ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 17:03
Regulatory News Service
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 67.0 KB
2025-11-28 17:03
Transaction in Own Shares
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 98.6 KB
2025-11-28 17:03
Transaction in Own Shares
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 2.4 KB
2025-11-10 22:00
Director's Dealing
Long-Term Incentive Plan - grant of share options to primary insiders - Attachm…
English 1.5 MB
2025-11-10 22:00
Remuneration Information
Long-Term Incentive Plan - grant of share options to primary insiders
English 2.3 KB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 272.3 KB
2025-11-06 07:00
Quarterly Report
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 1.7 MB
2025-11-06 07:00
Investor Presentation
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 2.9 MB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 6.5 KB
2025-10-30 13:46
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 resu…
English 1.1 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 184.8 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 4.8 KB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 2.8 MB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
English 2.8 MB
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 776 bytes

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArcticZymes Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Personalis, Inc. Logo
Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.
United States of America
PSNL
Perspective Therapeutics, Inc. Logo
Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.
United States of America
CATX
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea
208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan
2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain
PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy
PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea
217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea
214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany
PSG
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland
PHR

Talk to a Data Expert

Have a question? We'll get back to you promptly.